Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.995 USD | +4.35% | -2.23% | +20.74% |
02/04 | North American Morning Briefing : Stocks Seen -2- | DJ |
28/03 | Talis Biomedical Corporation Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Chart calendar Talis Biomedical Corporation
Upcoming events on Talis Biomedical Corporation
Past events on Talis Biomedical Corporation
14/11/2023 06:30 pm | Q3 2023 Earnings Release |
11/08/2023 02:00 am | Q2 2023 Earnings Call |
11/08/2023 01:35 am | Q2 2023 Earnings Release |
09/06/2023 08:00 pm | Annual General Meeting |
12/05/2023 02:00 am | Business Update Call - Q1 2023 |
12/05/2023 01:35 am | Q1 2023 Earnings Release |
23/03/2023 01:35 am | Q4 2022 Earnings Release |
04/11/2022 01:35 am | Q3 2022 Earnings Release |
03/08/2022 02:00 am | Business Update Call |
03/08/2022 01:35 am | Interim 2022 Earnings Release |
10/06/2022 08:00 pm | Annual General Meeting |
11/05/2022 02:00 am | Q1 2022 Earnings Call |
10/05/2022 | Q1 2022 Earnings Release After hours |
16/03/2022 02:00 am | FY 2021 Earnings Call |
16/03/2022 01:35 am | FY 2021 Earnings Release |
16/11/2021 03:00 am | Q3 2021 Earnings Call |
16/11/2021 02:35 am | Q3 2021 Earnings Release |
11/08/2021 02:00 am | Interim 2021 Earnings Call |
11/08/2021 01:35 am | Interim 2021 Earnings Release |
12/05/2021 08:30 pm | Bank of America Healthcare Conference |
Annual results
Fiscal Period | December | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 3,98 | 10,9 10,9 -0% | 8,19 8,49 -3.5% | 4,81 5,03 -4.29% |
EBITDA Million USD | Released Forecast Spread | 0,00 | -90,4 -81,2 -11.39% | -190 -196 2.71% | -106 -111 4.1% |
EBIT Million USD | Released Forecast Spread | 0,00 | -91,2 -81,8 -11.47% | -192 -197 2.46% | -115 -106 -8.92% |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | -192 -200 3.98% | -113 -104 -8.25% |
Net income Million USD | Released Forecast Spread | 0,00 | -91,1 -81,8 -11.4% | -192 -194 1.22% | -113 -105 -8.14% |
EPS USD | Released Forecast Spread | -134 | -645 -173 -273.09% | -127 -138 8.07% | -63,6 -58,9 -8.04% |
Announcement Date | 15/10/20 | 30/03/21 | 15/03/22 | 22/03/23 |
Quarterly results
Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 |
---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,86 1,33 -35.65% | 3,19 0,65 390.31% | 0,57 0,70 -18.29% | 0,80 0,31 159.56% | 0,26 0,78 -67.05% | 1,22 0,25 387.2% | 0,58 0,11 428.18% |
EBITDA Million USD | Released Forecast Spread | -27,6 -31,7 13.01% | -32,6 -31,0 -5.17% | -26,3 -23,0 -14.32% | -22,9 -21,0 -8.86% | -24,6 -20,0 -22.75% | ||
EBIT Million USD | Released Forecast Spread | -28,5 -33,5 14.91% | -33,0 -30,9 -6.86% | -27,3 -21,3 -28.04% | -26,8 -21,0 -27.84% | -28,1 -18,9 -48.74% | -19,0 -19,7 3.57% | -16,4 -15,9 -3.09% |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -28,7 -37,0 22.56% | -33,1 -30,0 -10.17% | -27,0 -21,3 -26.81% | -26,0 -19,3 -35.17% | -26,9 -18,7 -44.39% | -17,8 -19,5 8.56% | -15,0 -14,9 -0.9% |
Net income Million USD | Released Forecast Spread | -28,7 -31,3 8.38% | -33,1 -30,0 -10.17% | -27,0 -21,3 -26.81% | -26,0 -20,8 -24.98% | -26,9 -18,7 -44.24% | -17,8 -19,5 8.56% | -15,0 -14,9 -0.9% |
EPS USD | Released Forecast Spread | -16,3 -17,9 9.28% | -18,7 -17,1 -9.95% | -15,1 -12,1 -25.42% | -14,7 -11,7 -25.51% | -15,0 -10,3 -45.81% | -9,90 -11,0 9.67% | -8,27 -8,25 -0.24% |
Announcement Date | 15/03/22 | 10/05/22 | 02/08/22 | 03/11/22 | 22/03/23 | 11/05/23 | 10/08/23 |
Today 04:00 pm | MODERNA, INC.: Q1 2024 Earnings Release |
Today 04:30 pm | BLUEPRINT MEDICINES CORPORATION: Q1 2024 Earnings Release |
Today 04:30 pm | KYMERA THERAPEUTICS, INC.: Q1 2024 Earnings Release |
Today 04:30 pm | IQVIA HOLDINGS INC.: Q1 2024 Earnings Release |
Today 05:30 pm | ALNYLAM PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
06/05/2024 | REVOLUTION MEDICINES, INC.: Q1 2024 Earnings Release (Projected) |
06/05/2024 | SYNDAX PHARMACEUTICALS, INC.: Q1 2024 Earnings Release (Projected) |
07/05/2024 | FORTREA HOLDINGS INC.: Q1 2024 Earnings Release |
07/05/2024 | VERVE THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
07/05/2024 | OLEMA PHARMACEUTICALS, INC.: Q1 2024 Earnings Release (Projected) |
Past sector events for Talis Biomedical Corporation
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- TLIS Stock
- Calendar Talis Biomedical Corporation